A detailed history of Great West Life Assurance CO transactions in Astrazeneca PLC stock. As of the latest transaction made, Great West Life Assurance CO holds 506 shares of AZN stock, worth $39,134. This represents 0.0% of its overall portfolio holdings.

Number of Shares
506
Previous 360 40.56%
Holding current value
$39,134
Previous $24,000 41.67%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

BUY
$61.03 - $69.57 $8,910 - $10,157
146 Added 40.56%
506 $34,000
Q4 2023

Feb 13, 2024

SELL
$61.89 - $69.28 $43,323 - $48,496
-700 Reduced 66.04%
360 $24,000
Q3 2023

Nov 14, 2023

BUY
$64.85 - $71.7 $34,370 - $38,001
530 Added 100.0%
1,060 $72,000
Q2 2023

Aug 10, 2023

SELL
$69.91 - $75.81 $127,166 - $137,898
-1,819 Reduced 77.44%
530 $38,000
Q1 2023

May 12, 2023

BUY
$63.15 - $71.6 $60,434 - $68,521
957 Added 68.75%
2,349 $163,000
Q4 2022

Feb 10, 2023

BUY
$54.21 - $70.44 $18,865 - $24,513
348 Added 33.33%
1,392 $94,000
Q3 2022

Nov 01, 2022

BUY
$53.02 - $135.75 $55,352 - $141,723
1,044 New
1,044 $57,000
Q2 2022

Aug 09, 2022

BUY
$59.26 - $71.14 $14,874 - $17,856
251 Added 47.81%
776 $51,000
Q1 2022

May 12, 2022

BUY
$55.72 - $67.12 $14,821 - $17,853
266 Added 102.7%
525 $36,000
Q4 2021

Feb 14, 2022

SELL
$54.02 - $63.83 $18.2 Million - $21.5 Million
-336,199 Reduced 99.92%
259 $15,000
Q3 2021

Nov 15, 2021

BUY
$55.56 - $60.79 $18.7 Million - $20.5 Million
336,458 New
336,458 $20.3 Million
Q4 2017

Feb 09, 2018

SELL
$32.09 - $34.78 $10.2 Million - $11 Million
-316,751 Closed
0 $0
Q3 2017

Nov 09, 2017

BUY
$28.96 - $34.0 $9.17 Million - $10.8 Million
316,751
316,751 $10.7 Million

Others Institutions Holding AZN

About ASTRAZENECA PLC


  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $240B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track Great West Life Assurance CO Portfolio

Follow Great West Life Assurance CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Great West Life Assurance CO , based on Form 13F filings with the SEC.

News

Stay updated on Great West Life Assurance CO with notifications on news.